HomeNews

News

  • Unprecedented demand for Aimovig reflects strong unmet need in Migraine, says Novartis CEO

    • July 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Antiherpetic medications reduce Alzheimer’s dementia risk by a factor of 10, says latest research

    • July 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive Ph 3 results announced for Zogenix’s ZX008 in Epilepsy Trial

    • July 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Herantis initiates CDNF development program for Parkinson’s disease

    • July 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Scientists discover genesis of Alzheimer’s, call it a “Big Bang” for the disease

    • July 12, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE advises restricted use of antibiotics for COPD

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • MANF Therapeutics announces positive data in Parkinson’s model

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ANAVEX®2-73 approved to initiate trial for Alzheimer’s & Parkinson’s Disease

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ICER report gives thumbs up to Aimovig for Chronic Migraine patients

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Biomarkers identified for Progressive Multiple Sclerosis

    • July 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more